With the objective of motivating the scientific community to continue with its excellent investigations and to renew its impetus to help others, the prize awarded by the Cura Project Institute has already recognized renowned Brazilian professionals in its previous editions
The 5th Renata Thormann Procianoy Award, announced during the Best of ASCO (American Society of Clinical Oncology) 2023, will take place in São Paulo on June 16, the event, more than providing due recognition, seeks to motivate the scientific community to continue with its excellent investigations and renew its impetus to help the next and future generations, since it works in research in Brazil
can be challenging and draining due to lack of incentives.
In a ceremony that takes place annually as part of the main program of the Best of ASCO, — organized by LACOG (Latin American Cooperative Oncology Group) and Ethics — Research and Teaching, the Cura Project Institute has been awarding the award since 2019 that selects the best Brazilian work submitted to the Annual Meeting of the American Society of Clinical Oncology (ASCO).
As explained by the President of the Cura Project Institute, Fernanda Schwyter, the Renata Thormann Procianoy Prize is evaluated by a scientific committee made up of research doctors associated with LACOG.
Throughout its editions, the Renata Thormann Procianoy Prize has honored important and recognized Brazilian professionals, such as:
The award ceremony for the 5th Renata Thormann Procianoy Prize will be held at an event for guests in São Paulo and the dissemination may be followed by the Social Networks of the Cura Project Institute.
About the Renata Thormann Procianoy Award
Inspired by the story of the psychiatrist and researcher Nora Thormann Porcianoy, who had the help of her daughter Renata Thormann Procianoy in the search for research that would help diagnose and cure her health problem, which, after two years, resulted in the inclusion of Nora's case in a clinical study coordinated by the Brazilian Dr. Roberto Miranda at the MD Anderson hospital, the University of Texas (USA), the Prize is a recognition of the research that identified and treated Nora. The name is a tribute to Renata who, unfortunately, months later suffered a car accident and died, celebrating her tenth birthday this year. Check out Nora Thormann Procianoy's testimony:
https://youtu.be/ohLeWAOaBkg
About the Cura Project Institute
The Cura Project Institute, a non-profit entity, promotes social, scientific and educational activities to increase civil society's awareness of the benefits of clinical research and to raise funds to finance academic studies to combat cancer in Brazil.
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
With 704,000 new cases of cancer expected per year in Brazil, the Cura Meetings event created by the Cura Project Institute reinforces the need to make society aware of the benefits of clinical research
The Cura Project Institute is holding the fourth edition of Cura Meetings, a meeting that aims to continue an important debate with representatives from different health sectors and to outline strategies to expand patients' access to research in Brazil. With the theme “Expanding the population's access to Clinical Research”, the event, online and free, is supported by the Latin American Cooperative Oncology Group (LACOG) and the ETHICS Institute - Research and Teaching.
The 4th Cura Meetings will take place on June 16, from 14:00 to 17:00 in São Paulo and will have a face-to-face format for guests and will be transmitted online, in order to expand the knowledge and dissemination of this very important topic. To have access to the broadcast, the public must register online and free of charge, Through the link and fill out the form. After that, registrants will receive the information to follow the event, wherever they are.
Cura Meetings is already part of the Cura Project Institute's calendar of actions, and has already brought to its discussion table multiple relevant actors involved in the scenario, such as the medical community, researchers, patient associations, the pharmaceutical industry, public authorities (Ministry of Health), the medical community, representatives of clinical research centers and CROs.
According to Fernanda Schwyter, President of the Cura Project Institute: “Cura Meetings is part of the actions to mobilize directly or indirectly to support the cause that the Cura Project Institute works on a daily basis. The expected result is society's commitment to funding studies
clinicals/academics promoting the best treatment of patients, especially cancer”.
With the presence of approximately forty authorities, doctors and members of civil society, the 4th Cura Meetings announces its preliminary schedule (subject to change). Check it out:
4TH CURA MEETINGS SCHEDULE - June 16, 2023:
14 at 14:15 - Overture
14:15 to 14:30 - 1st Conference: Health in Brazil and the World and the impact of
Clinical Research in the evolution of health systems - Dr. Nelson Teich - Doctor
Oncologist and Master in Health Economics
14:30 to 14:45 - 2nd Conference: Pharmaceutical Industry: Brazil in the context
worldwide - André Gomes - Head of Clinical Operation Bristol
14:45 to 15:00 - 3rd Conference: The challenges of academic clinical research in
Brazil - Dr. Andreia Melo - Head of Clinical Research at INCA
15:00 to 15:15 - halftime
15:15 to 16:45 — Debate
- Confirmed debaters:
16:45 to 17:00 - Final Thoughts and Closing
LEARN MORE AND SIGN UP FOR FREE
About Oncology Clinical Research
According to the 2023 Estimate on the Incidence of Cancer in Brazil released by the National Cancer Institute (INCA) of the Ministry of Health, the expectation is that there will be 704,000 new cases of cancer in Brazil per year from 2023 to 2025.
Under this scenario, scientific research is not only necessary but urgent, but to get an idea, only 2.3% of global studies are carried out in Brazil, and the average time for approval of clinical studies in the country is 215 days, much higher than countries such as Argentina (113 days), Mexico (86 days) and the United States (only 32 days). Barriers are also found for the institution
of these studies in Brazil, especially with regard to bureaucratic restrictions, multiple instances of government approval, unpredictability of the study approval schedule, restricted funding sources, lack of public interest and patient awareness.
Thus, in order for new drugs and improved protocols for cancer diagnostics, tests, and treatment to be available on the market to the population, several steps are necessary to obtain registrations for these products or procedures. This registration is only possible after the various phases of proving the efficacy and safety of the drug or procedure. This evidence is found in research trials, from basic research to clinical research, involving human beings.
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
May 31 is World No Tobacco Day and oncologist Dr. Suellen Nastri Castro speaks about the topic at the request of the Cura Project Institute
According to the WHO (World Health Organization), smoking is the leading preventable cause of illness and early death in the world, and is related to several serious diseases such as cancer, chronic obstructive pulmonary disease (pulmonary emphysema and chronic bronchitis), coronary artery disease (angina and heart attack), and stroke (also known as “stroke”). In addition, the use of tobacco is also related to conditions such as infertility and sexual impotence.
It is estimated that smoking is associated with one third of all diagnosed cancers. Globally, there are more than 8 million deaths a year related to tobacco, 7 million from active use and 1.2 million from passive exposure.
Brazil is considered an example, a reference, as one of the countries that smokes the least, due to the establishment of federal anti-smoking laws. As a result, these laws allowed for a significant reduction in smoking in the country.
According to Dr. Suellen Nastri Castro, oncologist, “quitting smoking promotes several health benefits for individuals, including those who already have complications associated with smoking. The cessation of smoking, at any age, allows a significant increase in a person's life expectancy, in addition to, of course, improving the quality of life”.
The specialist also reinforces the importance of the existence of smoking cessation programs in several hospitals/institutions across Brazil, and that they have several professionals who assist the individual in this process, offering follow-up, drug treatments and psychotherapy. “It is highly recommended to carry out periodic examinations for the early detection of serious diseases related to cigarettes, such as low-dose radiation tomography annually in a population at risk for lung cancer, such as people who are smokers, or former smokers, aged 50-80 years“, said the doctor.
For more information, talk to your doctor. If you can't quit smoking on your own, ask for help!
Collaboration:
Dr. Suellen Nastri Castro (CRM-SP 151.417) - Clinical Oncologist at Hospital BP — The Benedicência Portuguesa de São Paulo. Author of the book Overcoming Lung Cancer and Pleural Mesothelioma from the Overcoming Cancer Institute. Graduated in clinical oncology from the Brazilian Institute for Cancer Control in São Paulo (now São Camilo Oncology)
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
Action #TheMagalWay will benefit the Cura Project in a donation campaign
A campaign #TheMagalWay - Cycling to support cancer research, emerged in the life of Brazilian Marcos Magalhães, who lives in the United States, as a way to explore his passion for bicycle competitions to inspire people to practice physical activities and raise funds for a good cause: cancer research.
In this year's season, Marcos Magalhães will participate in several cycling events, the most important of which is a journey through the Patagonian Pampas, traveling across lakes and mountains along Chile's iconic Carretera Austral and Pacific fjords. This will take place in November of this year, in “Blue November”, which is a month dedicated to raising awareness about men's health problems, focusing on prostate cancer.
And for that journey, Marcos chose the Cura Project Institute to benefit from the donations collected in the action, which, in the words of the cyclist himself: “I set an ambitious goal because we know that, with the support of people like you, we can achieve it. Please be sure to make your donation and follow my journey at @themagalway” — explains the athlete.
Learn more about the #TheMagalWay journey, following the cyclist Marcos Magalhães on his Social Networks @themagalway and, to participate with a donation, simply log in and access the link: https://projetocura.org/c/themagalway/
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
The Cura Talks event brought together patients, families, companies, NGOs and health professionals and a Free Conference of the National Health Council was held.
On March 31, Cura Talks took place, with the theme “What You Should Know About Research and Cancer: Challenges and Opportunities”. The event, presented by ONE - Ocean Network Express, with the support of LACOG - Latin American Cooperative Oncology Group and about 20 other health institutions as institutional support, took place at the Hotel Intercontinental, in São Paulo - SP.
With more than 100 people present and more than 80 watching the live broadcast, the public can attend lectures and debates with Dr. William William (oncologist), Caio Viana (psychologist), Leonardo Husz (nurse specializing in oncology) and Dr. Julio Antônio Pereira (oncologist), as well as testimonials from the patient Ana Cristina Angrisano and others present.
Cura Talks also included a Free Conference of the National Health Council, where a debate, proposal and the election of two Delegates, Fernanda Schwyter and Luciana Peixoto, who will participate in the 17th National Health Conference, with the objective of submitting proposals to increase access to research for cancer patients.
In addition, the Cura Project Institute paid a brief tribute to the people and companies that believe in and support our project and struggle. We register here our thanks to ONE, Alta Saúde, ICB, Clínica Prognostica and Silvana Nunes - donor and representative of individual donors.
Check out some images from our event!
To see more photos, click here.
Image credits: Jefferson Corrêa/RB Films
Those who were unable to attend the live event can check out the saved broadcast on our channel at youtube
https://www.youtube.com/watch?v=8bHPtgZuwIQ&t=15s
Cura Talks is another of the Cura Project Institute's proprietary events of many yet to come!
Be part of our community and take part in our actions!
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
The Cura Project Institute joins the fight to mobilize Civil and Medical Institutions and Societies against the #Veto59 of PRONON and PRONAS/PCD.
The Cura Project Institute joined hundreds of Civil Society Institutions and Medical Societies to create a mobilization to obtain, together with the Federal Government, the return of the PRONAS/PCD (National Health Care Support Program for the Disabled) and PRONON (National Oncology Care Support Program) Programs.
These programs brought significant investments in scientific research, training, and public access to innovative treatments that promoted advances in cancer care and rehabilitation for thousands of Brazilians.
This is the moment for everyone to come together to get parliamentarians, from the Senate and the Chamber, to overturn the veto of Bill 5,307/2020, authored by Senator Mara Gabrilli, which extends the possibility for private companies to donate funds to projects approved by the Ministry of Health in the areas of Oncology and Physical Rehabilitation, by deducting 1% from the Income Tax return, made by Real Profit.
Medicine has come a long way in recent years, but this is only possible with resources and, therefore, PRONON And the PRONAS/PCD They are essential. These resources are invested in actions for the SUS and in the care of the population that uses the system where, through various activities such as scientific research, purchase of equipment, training, among others, institutions can provide effective assistance to cancer patients and people with disabilities. The time has come to demand political participation on behalf of people in need.
Take part in this mobilization, nonpartisan and share!
Let's fight for the right to have inclusive and high-quality medicine!
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
The Cura Talks event takes place in São Paulo and will enlighten patients, NGOs and companies about Research and Cancer
On March 31, 2023, the Cura Project Institute will hold another proprietary event, the 1st Cura Talks. Under the theme “What You Should Know About Research and Cancer: Challenges and Opportunities”, O Cura Talks aims to promote knowledge and awareness about research that seeks a cure for cancer, as well as to engage patients, NGOs and companies to the cause.
Since its founding, Instituto Proyecto Cura has been holding social and corporate events to promote society's awareness, funding, and engagement in favor of research that seeks a cure for cancer.
Cura Talks, which has the support of LACOG - Latin American Cooperative Oncology Group -, will feature lectures by medical oncologists and other renowned specialized professionals in the field of research, who will share relevant and important information on the topic. For the opening of the event, which will address “Magnitude of cancer patient care”, we will have the important name of Dr. William William, a leading physician in clinical oncology, member of the Scientific Committee of the Cura Project Institute, Associate Adjunct Professor at the MD Anderson Cancer Center, Coordinator of the Thoracic Tumors Committee of the SBOC (Brazilian Society of Clinical Oncology) and President of the Head and Neck Cancer chapter of LACOG.
The first edition of Cura Talks will take place in a hybrid form, with a live broadcast and, subsequently, the conferences will be available on the digital platforms of the Cura Project Institute, so that this very important issue can be broadened and informed to more patients, support networks, other doctors and various supporters of the cause.
Check out the schedule:
13:30 — Welcome to the in-person audience
14H — Opening and Start of the online broadcast
14:15 TO 14:35 - Magnitude of cancer patient care - Doctor Oncologist Dr. William William
14:35 TO 14:55 - Myths and Truths about participating in Clinical Research — Psychologist Caio Vianna
14:55 TO 15:30 — Papo Cura: Ask your questions
15:30 TO 15:45 - halftime
15:45 TO 16:45 - Papo Cura: Understanding Everyday Clinical Research - Debaters: Nurse Specialized in Oncology Leonardo Husz and Clinical Oncologist Dr. Julio Antônio Pereira
16:45 to 17:30 — Cura Recognition — Delivery of Certificates and Closing
Learn more about the Cura Project Institute
The Cura Project Institute is a non-profit institution, based in Brazil (São Paulo) and unique in
Latin America, whose objective is to finance academic research in the area of oncology.
According to the World Health Organization, already in the next decade, two out of every three people will be
diagnosed with cancer, which is expected to become a true epidemic. The consolidation of the activity
Research is one of the solutions to meet the needs of the population, particularly those who
depends on the public health system, reducing discrepancies and facilitating access to the best
treatments for everyone.
Service:
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
The BIG - Breast International Group is the largest global network of academic research groups.
The history of the Institute Cura and BIG Project began in 2012 at an international scientific event, the Inter-American Breast Cancer Conference, in Cancun, where our president Fernanda Schwyter Did you meet the teacher Dr. Martine Piccart - president and co-founder of Breast International Group. It was at this meeting that the Cura Project Institute began to be designed, with the mission of carrying the message of the importance of international collaborative research to Latin America.
Some years later, in 2014, in Porto Alegre, when Cura was still being conceived, our president planned and coordinated a meeting between Dr. Piccart and Latin American researchers, the “BIG Latin American Groups Retreat”, an event that was held in Porto Alegre with the support of LACOG.
After that event, in the same year, Fernanda was invited to spend a week with the BIG team learning about Fundraising and awareness campaigns for research. This knowledge was essential for the development of Cura and is now strengthened with mutual institutional support!
To celebrate this moment, we interviewed the institution's team and brought their vision about the Cura Project Institute and the importance of the culture of philanthropy and of scientific research.
What is the importance of research for improving cancer treatment?
Research is the only way to improve cancer treatments — make them more effective, reduce their side effects, and adapt them to the individual needs of patients. This is because research is the only way to understand the biology of any specific form of cancer in order to determine the best possible way to treat it. Without research, we will not be able to cure cancer or end the great suffering and death of millions of people every year.
What is the biggest challenge for researchers to carry out research? Get funding to carry out your research. But to do that, the general public and potential donors need to understand why research is important and how research can improve and save lives.
Why is it important to engage in campaigns?
They serve to inform the general public and all those who can potentially play a role in supporting research. Campaigns can explain the importance of research, dispel myths about research, and show concretely how research leads to better treatments and cures for diseases such as cancer.
What are the direct and indirect benefits for patients?
Research leads to new treatments, which can extend patients' lives and improve quality of life; it also leads to cures. Indirectly, research reduces human suffering and, by improving people's health, it also reduces the burden on health systems.
What is the importance of the CURA Project Institute in this scenario?
CURA plays a critical role in bringing people together to help increase cancer awareness in Latin America and explain the essential role played by global research and collaboration in tackling cancer. CURA also collects essential resources for research. Without this, research cannot advance, progress cannot be made, and lives will continue to be lost because of cancer.
What is the importance of the CURA Project Institute for BIG's achievements?
CURA contributes to the success and strength of BIG member groups based in Latin America, in particular LACOG (Latin American Cooperative Oncology Group). In this way, LACOG can continue to develop important studies on breast cancer to be conducted in Brazil, Latin America and other regions, and its researchers can share their knowledge and experiences in Latin America. This helps to make global BIG studies more relevant to patients wherever they are in the world.
How can we count on BIG in developing a culture of philanthropy for research in Latin America?
The vision of the Breast International Group (BIG) is to find cures for breast cancer, facilitating collaboration between its academic research groups located around the world. Its primary purpose is to develop and execute breast cancer clinical trials and research programs that answer important questions for patients. To help raise funds for BIG studies with few resources, BIG established its own philanthropic team called “BIG against breast cancer”. This team and the leadership at BIG's headquarters in Brussels, Belgium, are available to advise LACOG and the CURA Project on their philanthropic initiatives.
About BIG
Breast International Group is a non-profit organization that represents the largest global network of academic research groups dedicated to finding better treatments and cures for breast cancer, with headquarters in Brussels, Belgium.
This long-standing interaction has now been transformed into an official partnership where BIG supports Cura institutionally!
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
Institutions Cura and Abrale carried out actions in partnership to promote the promotion of Leukemia Awareness Month.
O Cura Project Institute and ABRALE - Brazilian Lymphoma and Leukemia Association came together once again in favor of a noble cause: raising awareness about Leukemia, in celebration of Orange February - a month that marks various initiatives on the subject. This partnership is part of the “Research Save Lives Movement” campaign, initiated by Cura, to inform and educate about the importance of clinical research in the fight against cancer.
Since the beginning of February, the Cura Project Institute has engaged in digital actions together with the NGO. First, we support the campaign #VaiDeLenço, which was linked to World Cancer Day, which was February 4th.
In addition, throughout the month, there were also:
About Leukemia
Leukemia is a malignant disease of white blood cells, generally of unknown origin, characterized by the replacement of normal blood cells, which give rise to the accumulation of diseased cells in the bone marrow.
It is very important that early diagnosis to increase the chances of curing this type of cancer, which may present symptoms such as: anemia resulting from reduced red blood cells (fatigue; shortness of breath; palpitation; headache); reduction of white blood cells (low immunity, which leaves the body more prone to infections); decreased platelets (bleeding generally in the nose or gums; purple spots - ecchymoses and purple spots on the skin).
Exposure to pesticides, solvents, diesel, dust, hepatitis B and C virus infection: leukemias
Early diagnosis is very important to increase the chances of curing this cancer, which may present symptoms such as anemia resulting from reduced red blood cells (fatigue; shortness of breath; palpitation; headache); reduction of white blood cells (low immunity, which leaves the body more prone to infections); decreased platelets (bleeding generally in the nose or gums; purple spots - ecchymoses and purple spots (petechiae) on the skin).
Also, how are these Diseases don't choose age, it is important to always be alert, especially in children and the elderly.
About ABRALE
A ABRALE (Brazilian Lymphoma and Leukemia Association) is a non-profit, national organization created in 2002 by patients and families with the mission of offering help and mobilizing partners so that all people with cancer and blood diseases have access to the best treatment.
The institution has a headquarters in São Paulo, with more than 60 employees who work in different areas, as well as a staff of 13 external representatives in the following cities: Belo Horizonte, Brasília, Campinas, Curitiba, Florianópolis, Fortaleza, Goiânia, Juiz de Fora, Recife, Ribeirão Preto, Rio de Janeiro, Salvador and São Paulo, and also has approximately 200 active volunteers, who help carry out actions for health and well-being. To learn more about ABRALE, visit the website And the Instagram.
We were very grateful for this additional support from ABRALE and for the opportunity for collaboration between NGOs. Always count on us!
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
The Institute presents a retrospective of educational events and actions in favor of scientific research.
In another year of holding events, face-to-face lectures, live shows, awards and much more, Cura Project Institute Celebrate your 6 years of existence and promotes dialogues between the main actors of cancer care in Brazil.
In addition to educational posts on social networks for the dissemination of quality information about cancer and research, Cura continued with its Periodical lives that had been started in 2021. Foram 11 in total, including partners, patients, NGOs, doctors, and others.
There were several participations in face-to-face and online events, such as the lectures of PRio, Brazilian Breast Cancer Conference, from the Academy for Media and Patients with Information and Science (Gramado Breast Cancer), at the London Global Cancer Week and the LACOG Immuno-Oncology Symposium.
In June, the 4th edition of Renata Thormann Procianoy Award which, since 2019, recognizes the work of Brazilian researchers with cancer research. That year, the winner was Dr. Verônica Torres (ICESP). She was the principal investigator, with Dr. Gilberto Castro as co-author, of the “Prospective study evaluates the performance of the 2021 CKD-EPI equation without racial coefficient in adults with solid tumors”, on aspects related to the care of renal treatment in cancer patients. Before her, we had winners Dr. Luciana Landeiro (2021), Dr. Fernando Maluf (2020) and Dr. Thiago Bueno (2019).
The Cura Project Institute also celebrated its title, provided by the Ministry of Justice, as an OSCIP - Civil Society Organization of Public Interest. The purpose of this title is to:
📌 facilitate partnerships and agreements with all levels of government and public bodies;
📌 allow donations made by companies to be deducted from income taxes.
This was another important step that will help with the purpose of raising funds to finance research to combat various types of cancer.
A series of their own events also took place, such as:
Still in October, Cura Project Institute launched a very important campaign, the “Research Save Lives Movement”, which aims to help clarify the benefits and their nuances from the point of view of the cancer patient. To learn more click here and check out the video, with the patient's testimony I'm going to Fluminham.
https://youtu.be/K2g64R_ws7k
In addition to all initiatives, the Cura Project Institute's social networks are still available for wide dissemination of scientific studies that are recruiting patients. To learn more and submit research from your center for outreach, send an email to campanhas@projetocura.org
We wish 2023 to arrive full of partnerships and achievements, counting on the support of everyone who was with us in 2022! May we all take advantage and set as goals for next year: to understand more about research, to help, and to share correct information on the topic!
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at campanhas@projetocura.org
The initiative is yet another source of information about the benefits of clinical research and its nuances from the point of view of the main beneficiary: the cancer patient.
It is through clinical research that medicine evolves. These studies are essential so that we can learn more about diseases, develop new drugs, vaccines, treatments, and tests. COVID-19 brought the world's population the spotlight on the importance and benefits of research to save millions of lives where, in an international effort and in record time, science, through doctors and researchers, brought the solution to the pandemic.
As with COVID 19, a cure for cancer is also in research, but for this, it is necessary to overcome many challenges, especially in Brazil, including: funding, awareness, regulation, and encouragement of scientific production.
And it was in view of these challenges that the Cura Project Institute devised the “#PesquisasSalvamVidas Movement” campaign. The objective is to generate engagement from all sectors of society that can act in favor of these researches that seek a cure for cancer, from regulation to the viability of clinical studies. The initiative will also provide social education and clarify the benefits of clinical research and its nuances from the point of view of the main beneficiary: the patient.
The campaign was launched in Pink October 2022, on the occasion of the Cura Meeting event, but the campaign still has no definite date for its completion, as it will gain strength with the engagement and support of various entities, groups and NGOs engaged in initiatives involving the fight against cancer.
The video that launched the “Research Saves Lives” Movement features the testimony of Iramara Fluminhan, a cancer patient who was diagnosed with metastatic breast cancer 8 years ago and is now only alive today thanks to research. Learn about Iramara's inspiring story in this video:
https://youtu.be/K2g64R_ws7k
About the Cura Project Institute
Founded in 2016, the Cura Project Institute is a non-profit institution, based in Brazil and unique in Latin America, whose objective is to finance academic research in the area of oncology. To learn more about Cura, click here
To learn more about the #PesquisasSalvamVidas Movement, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
To make a donation and learn more about our projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
In another year of actions, the Pink October events and actions held by the Cura Project Institute were a success.
The month dedicated to the fight against breast cancer had important events for the Institute
Cura Project, which held two events: the 3rd Cura Meetings and the 1st Immunotherapy Forum for Patients, which took place on October 7th and 8th in São Paulo.
Both events addressed essential issues in favor of Clinical Research in Brazil. As they took place in a hybrid way, they allowed the participation of a large audience, coming from different parts of Brazil.
Addressing the topic “Clinical Research as a Form of Social Inclusion - Expanding the
access to Clinical Research in Brazil”, to 3rd Edition of Cura Meetings It was attended by
renowned medical researchers, representatives of NGOs, patients, the Pharmaceutical Industry, in addition to
important participation of the Ministry of Health and Anvisa. The event, which took place on October 7, promoted an unusual discussion between these important decision-making fronts regarding Clinical Research.
CLICK HERE and check out the recording of the 3rd Cura Meetings event
Already 1st Immunotherapy Forum for Patients, which took place on October 8, provided many significant explanations about immunotherapy - one of the most current and innovative types of cancer treatments. This knowledge was presented in a simple and didactic manner, making it easier for the public to understand. This was a good opportunity for the audience, in person and online, to ask questions about the topic.
Renowned oncologists and researchers were part of the Forum, such as Dr. Gustavo Werutsky - president of LACOG (Latin American Cooperative Oncology Group), Dr. Heloisa Resende - president of the Scientific Committee of the Cura Project Institute, Dr. William William and Dr. Lilian Arruda - members of the Cure Committee and Dr. Jose Márcio Figueiredo - director of the Cancer Institute Brazil. These are all medical professionals who go hand in hand with the Cura Project.
CLICK HERE and check out the recording of the 1st Immunotherapy Forum event for
Patients
Along with the events, the Cura Project Institute also launched
warfare “Research Save Lives Movement”, who seeks to raise awareness about
importance of scientific research. To be aware and to be able to engage with the cause,
Follow our social networks @projetocura
Watch the exciting campaign launch video BY CLICKING HERE.
Still as part of the actions of Pink October, the Cura Project Institute was held on the 13th of
October, at Prio, in Rio de Janeiro, speaking to the company's employees about prevention and the importance of early diagnosis of breast cancer, through a lecture by Dr. Jose Bines, and also about how important clinical research is for cancer patients and for society, with the participation of the President of Cura, Fernanda Schwyter.
On October 24, the Cura Project Institute participated in an online chat with
employees of Arteris, through the collaboration of the oncologist Dr. Ricardo Caponero and from the President of Cura, Fernanda Schwyter.
On October 25, Fernanda Schwyter and the vice-president of the Cura Project Institute, Alcina Mara, participated in TurniCast, a podcast hosted by Leandro Caleguer and Vitor Dias, about the importance of scientific research in the fight against cancer.
https://youtu.be/4rNcNipNUQM
Our objectives in participating in live shows and lectures at various companies are those of to make society aware of the benefits of research to combat cancer and to engage them in actions to obtain resources to finance studies.
To learn more about the Cura Project projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
Another event from the Cura Project Institute will take place on October 8.
The Cura Project Institute will hold, on October 08, at the WTC Sheraton, in São Paulo, the “Forum
of Immunotherapy for Patients”. The event aims to improve patient outcomes
oncological diseases in Brazil through the evolution of science and research. Cura hopes to educate and equip patients, family members, and patient association leaders, presenting the
opportunities to participate in clinical studies such as access to new treatments, such as
immunotherapy.
Over the past 10 years, a large investment has been made in oncology research in
search for new therapeutic options that improve patients' quality of life and increase
chances of cure and/or control of the disease. One of the main treatments that has shown promise
it's immunotherapy. It is a type of treatment, with a medication that boosts the person's immune system so that the body can fight cancer more effectively. The adverse event profile (side effects) is different from traditional chemotherapy and has been well tolerated by most patients.
Immunotherapy is being studied through clinical research in various types of cancer, such as breast, lung, stomach, bladder, kidney, colon and melanoma cancers. However, each type of cancer responds differently to immunotherapy, alone or combined with other treatments, such as chemotherapy. There is still a long way to go in the sphere of knowledge about immunotherapy, understanding, for example, which patients will benefit the most from this type of treatment, and for this reason, clinical research in oncology plays a fundamental role.
That is why we must continue to invest so much in the development of new clinical research with
immunotherapy, as well as empowering patient associations, activist patients and their families, which
It is immunotherapy, what is clinical research and how to participate in studies, demystifying stigmas and
clarifying doubts.
Given the relevance of the topic, it is necessary to unite efforts between the medical profession and public policies
adequate and good level of clarification from patients and patient support associations.
Considering this objective, the Cura Project Institute will hold the 1st Immunotherapy Forum for Patients with the theme “Clinical Research as a form of access to immunotherapy”. The forum will reach an audience of NGO leaders, patients and doctors and will be presented in a hybrid form, where the public can follow the Cura Social Networks, where the link will be available to follow the event online.
Check out the schedule:
11 a.m. to 11:15 a.m. - Aperture
MODULE 1
O 11:15 to 11:35 - Conference 1 (Dr. Heloisa Resende) - Was every treatment once a research?
What Are the Different Types of Cancer Treatments?
O 11:35 to 11:55 - Conference 2 (Dr. William William) - Immunotherapy Concept. What changes
with Immunotherapy? Advantages and disadvantages of treatment. For what types of cancer
Do we have immunotherapy?
O 12:00 to 12:20 - Conference 3 (Dr. Gustavo Werustsky) - Research as a way of accessing
patients to immunotherapy. How can we optimize this strategy? There are researches being
developed by LACOG and other Immunotherapy institutions in Brazil?
O 12:20 to 12:30 - Interval
MODULE 2
O 12:30 to 13:30 - Discussion/Questions (Dr. Heloisa Resende and Dr. Lilian Arruda) - What is the role
of NGOs with Clinical Research?
Making the patient aware of becoming a research patient.
How to approach patients to participate in clinical studies?
Or 13:30 to 14:00 - Closing
About the Cura Project Institute
The Cura Project Institute is a non-profit institution, based in Brazil and unique in
Latin America, whose objective is to finance academic research in the area of oncology.
According to the World Health Organization, already in the next decade, two out of every three people will be
diagnosed with cancer, which is expected to become a true epidemic. The consolidation of the activity
Research is one of the solutions to meet the needs of the population, particularly those who
depends on the public health system, reducing discrepancies and facilitating access to the best
treatments.
To learn more about the Cura Project projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
Through the “Cura Meetings” meetings, the Cura Project Institute promotes knowledge and access to Clinical Research in Brazil
With the objective of expanding the knowledge and engagement of different sectors of civil society
to reduce the cancer incidence in Brazil, the Cura Project Institute launched a project that carries out
periodic meetings called “Cura Meetings”, which promote discussions between renowned doctors
of the area, on various topics and giving the public the opportunity to learn about the benefits and
challenges for carrying out research in the fight against cancer.
With two successful editions already held, Cura Meetings premiered in April this year
year. The first edition, held at the Best of San Antonio Breast Cancer Symposium, organized by GBECAM — LACOG, in São Paulo, held three meetings: Cura Meetings Donors, Cura Meetings
NGOs, focusing on the topic “Clinical Research and Social Inclusion”, and Cura Medical Meetings.
Already in its second edition, which took place in June of the same year, Cura Meetings had as its theme “The challenges of public policies aimed at regulating and encouraging oncological research in Brazil”, raising a discussion about an essential area for confronting cancer in our country. In this edition, which took place on the occasion of the Best Of Asco 2022 Annual Meeting in São Paulo, the meeting put aside common interests and the importance of joint efforts in social mobilization for the reactivation of the PRONON program — National Oncology Care Support Program, which had its regulations expired at the end of 2021.
The next Cura Meetings will take place on October 7th, from 14:00 to 17:30, at the WTC Sheraton São Paulo, in a hybrid form (in person and online), and will address the topic “Clinical Research as a Form of Social Inclusion - Expanding Access to Clinical Research in Brazil”, aimed at encouraging the development of new research and the need to encourage new public policies and technologies to promote the improvement of patient outcomes.
At the time, an important campaign will also be launched in favor of Clinical Research in Brazil. Headed by the Cura Project Institute, “Clinical Research Movement” It will aim to develop
together with other institutions, including patient NGOs, a movement that aims to raise awareness and
promote a discussion between regulatory bodies, such as the Ministry of Health, ANVISA (National Health Surveillance Agency) and CONEP ( National Research Ethics Commission) with
medical community, research, industry, and patient support associations.
Once again, the Cura Project Institute is leading the way in promoting education and carrying out effective actions to encourage support for clinical research as a way to combat cancer and save lives!
About the Cura Project Institute
The Cura Project Institute is a non-profit institution, created in 2016, with headquarters in Brazil and unique in Latin America, whose objective is to finance academic research in the area of oncology. Cura works both online, through the website and social networks, and offline, with the holding of scientific, social and artistic events, mobilizing civil society and companies.
According to the World Health Organization, already in the next decade, two out of every three people will be
diagnosed with cancer, which is expected to become a true epidemic. The consolidation of the activity
Research is one of the solutions to meet the needs of the population, particularly those who
depends on the public health system, reducing discrepancies and facilitating access to the best
treatments.
To learn more about the Cura Project projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
Oncologist Dr. Ricardo Caponero clarifies doubts about the relationship between breastfeeding and breast cancer.
Breast cancer is a disease that can, in some cases, be prevented. This prevention, in general, consists of removing risk factors as early as possible.
Some cases of this neoplasm have a hereditary risk component. Today, we know about 21 genes related to breast cancer. In these cases, for eligible patients, prophylactic surgeries may reduce this risk. In addition, this group of women may be candidates for screening tests started when they are younger, with more specific exams and with shorter intervals.
However, most breast neoplasms do not have a hereditary character. For these, environmental factors may be the most relevant. Exposure to tobacco and its derivatives, excessive consumption of alcoholic beverages and various chemical substances are relevant, as is exposure to hormonal (estrogenic) stimuli.
All women produce estrogens, but some factors increase their action, such as hormone replacement therapy and the use of some types of contraceptive pills (those with low risk). Hormone replacement is not prohibited, but it should be done with caution, in properly selected patients, for the shortest possible time and, most importantly, with medical supervision.
Weight gain, especially after menopause, is also a risk factor. In addition to storing estrogens, fat has a higher concentration of an enzyme, called aromatase. The increase in fat mass composition also contributes to the generation of a systemic inflammatory state, which contributes to an increased risk of neoplasms in general and, in particular, for breast and endometrial cancer.
Diet (low in fat) and regular exercise are the two main modifiable factors for cancer prevention and should be started as early as possible (preferably in childhood).
The onset of periods at a younger age, the later menopause, no
having had children or having started procreation later and not breastfeeding also contribute
for a longer time of exposure to estrogen.
Pregnancy and breastfeeding also stimulate the maturation of breast cells to produce milk, and this is a factor for the good differentiation of breast tissue
We do not recommend any method to delay the first menstruation or to anticipate menopause
as a way to prevent cancer. In the same way that we cannot recommend that
women have many children, at the lowest possible age, for the same purpose. Essa
The measure causes very lasting social and economic impacts.
Breastfeeding is related to pregnancy, obviously. There are doubts regarding
At the optimal length of the breastfeeding period, most pediatricians recommend that she
occurs in the baby's first six months and may extend up to one year of age in
poorer populations, with fewer resources to provide an adequate alternative to
child feeding. Breastfeeding is a physiological act and has effects on the immunity of
newborn and in their physical and psychological development.
Although breastfeeding contributes to the reduction in the incidence of breast cancer,
its effect is very small when compared to other risk factors. We don't know your
impact on patients with hereditary mutations and their benefit is very small in
patients with other risk factors, such as obesity, sedentary lifestyle, smoking, etc.
A review of epidemiological data shows that the protective biological mechanism of breastfeeding remains unknown, although it is posited that it results from hormonal changes, such as estrogen reduction; removal of estrogens through breast fluid; excretion of carcinogens from breast tissue through breastfeeding; physical changes in mammary epithelial cells, reflecting maximum differentiation; and delayed reestablishment of ovulation.
Although breastfeeding is a potentially modifiable behavior, the practical implication of reducing the risk of breast cancer among premenopausal women with prolonged breastfeeding duration may be of marginal importance (less than 1% impact), particularly in Western societies.
Primary prevention of breast cancer is possible, but it depends on a set of measures so that it can be as effective as possible and, very importantly, it does not require adequate screening tests, which, although they do not reduce the incidence, are essential for simpler, less mutilating treatments and with greater chances of cure.
To conclude, breastfeeding is good, it should always be recommended, but its impact as a protective factor in breast cancer is very small.
Ricardo Caponero
— CRM 51,600/SP
Clinical Oncologist at the German Hospital Oswaldo Cruz
Oncologist Dr. Anelisa Coutinho explains a study presented at ASCO on the use of medication that
demonstrated 100% clinical response in a specific subgroup of patients with rectal cancer
When it comes to cancer, the greatest expectation is to have effective medications that can promote the cure of patients affected by this disease. Recently, the results of an important study dominated the national and international media in a surprising way.
This is a very small study that evaluated a medication called DOSTARLIMAB in patients with locally advanced rectal adenocarcinoma, stages II and III, with a genetic alteration
specifies: microsatellite instability or deficiency of DNA repair enzymes.
A microsatellites instability (MSI-H) it is an alteration found in less than 5% of patients with rectal cancer, i.e., approximately 95% of patients with this disease do not have this alteration. Based on data from studies on colorectal cancer and other tumors, it is known that patients with MSI-H are more susceptible to a form of treatment called immunotherapy, and DOSTARLIMAB It is a drug that belongs to this class of medications.
Treatment for locally advanced rectal cancer usually consists of radiation therapy, chemotherapy, and surgery. The idea of the authors of the work that was presented by Dr. Andrea Cercek at the largest American oncology congress, the ASCO congress, held in Chicago-USA this year, was to offer immunotherapy as initial treatment to patients with rectal cancer locally
advanced, assess the response after 6 months of treatment and only offer standard forms of treatment (radiotherapy, chemotherapy, followed or not by surgery) if there is no response to the experimental treatment.
The good surprise is that there was a complete clinical response, i.e. the absence of any evidence of residual tumor, in the first 14 patients evaluated.. The authors' expectation is to have a sample with at least 30 patients for this study, which is still ongoing. The number of patients is still small, the follow-up period after treatment is still short (median of 6.8 months), and
patients are still under observation. But without a doubt, this is already an excellent result, which can effectively modify the way of treating this special subgroup of patients with microsatellite instability, with a high response rate and saving them from side effects usually related to standard radiation therapy, chemotherapy and surgery.
Today, in oncological practice, microsatellite instability testing is already recommended for all patients with colorectal cancer, both for screening for a genetic syndrome called Lynch syndrome and to better guide treatment choices, as in the case of this study. The test is simple and widely available in many pathology laboratories, and is performed initially
in the tissue material from the tumor biopsy.
Science has evolved and we have learned to individualize treatments, identifying what best suits each patient and considering specific mutations that can be targeted by drugs aimed at these changes. The medical community and certainly the general population celebrated these results, which represent a lot and may favorably change the treatment perspective in this group of patients, but it should be noted that the still small number of
sample of the study, the prediction of a longer time for observing the results and the fact that it is applied to only a minority of patients with rectal cancer.
Anelisa K. Coutinho
Oncologist at AMO DASA
Member of SBOC, GTG, ASCO, ESMO
The Cura Project Institute engages with the Green July movement and provides information about these types of cancer
We're in #JulhoVerde, Head and Neck Cancer Awareness and Fight Month. The Cura Project Institute is also fighting to educate and demystify this type of disease.
Do you know where Head and Neck Cancer appears? These tumors affect the lips, tongue, floor of the mouth and roof of the mouth, sinuses, nasal cavity, tonsil, base of the tongue, pharynx, larynx, salivary glands, blood vessels, muscles and nerves in the region, and the thyroid gland.
But do you know the most common symptoms associated with these cancers that are often overlooked? Check it out!
They are highly preventable diseases!
It is important, in addition to the symptoms, to know the risk factors for diseases and to try to avoid them. They are:
- Avoid alcohol consumption
- Don't smoke
- Pray for oral hygiene
- Prevent HPV infection with vaccine and the use of condoms
Stay tuned!
One of the main problems for treating Head and Neck Cancers is the late diagnosis of diseases, which occurs in about 60% of cases, causing a significant loss of quality of life during and after treatment. But on the other hand, if diagnosed in the first stage, the chance of curing Head and Neck Cancer is greater than 80%.
Early diagnosis saves lives!
To learn more about the Cura Project projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
The researcher and nephrologist from the Cancer Institute, Dr. Verônica Torres, received the award at the Best of ASCO 2022 event.
On the same occasion of the Best of ASCO 2022 — Brazil Edition, the winner of the fourth edition of the Renata Thormann Procianoy Prize was announced. The winner was the researcher and nephrologist from ICESP — São Paulo State Cancer Institute, Dr. Verônica Torres Costa e Silva, principal investigator of a study on aspects related to renal treatment care in cancer patients.
Dr. Verônica Torres, who unfortunately cannot attend the event due to health reasons, was represented by the oncologist Prof. Dr. Gilberto Castro, physician and head of the head, neck and chest cancer group at ICESP Clinical Oncology and one of the co-authors of the study, who received the prize from the research patient Iramara Fluminhan and the President of the Cura Project Institute, Fernanda Schwyter.
About the research
The prospective study evaluates the performance of the 2021 CKD-EPI equation without racial coefficient in adults with solid tumors. Dr. Verônica Torres, lead author of the research, summarizes it as “the study on aspects related to renal treatment care in cancer patients” and is the best Brazilian poster presented during ASCO 2022. In addition to those already mentioned, the research also included the participation of Dr. Maria Del Pilar Estevez Diz and other researchers from ICESP.
The results of the study show that the coefficient associated with race must be removed from the equations to assess the estimated glomerular filtration rate, which represents an advance and must be incorporated into cancer treatment, the authors conclude.
For a better understanding of the research and with an explanatory approach for the general public, the Cura Project Institute, mediated by its President, Fernanda Schwyter, held a live on June 21 on Cura's Instagram profile (http://www.instagram.com/projetocura), with the participation of the award winner and lead author, Dr. Verônica Torres, together with co-author Dr. Gilberto Castro. The live show was also attended by Dr. Luis Fernando Correia, doctor and CURA ambassador. Check out the video recording hereto!
About the prize
Designed by the Cura Project Institute, the Renata Thormann Procianoy award was launched in 2019 and aims to make society aware of the benefits of research, valuing and encouraging medical researchers. In its previous editions, Dr. Thiago Bueno, Dr. Fernando Maluf and Dr. Luciana Landeiro were winners.
The story behind the creation of the award is about “a story of love and pain”, as the President of the Cura Project Institute, Fernanda Schwyter, always stresses when describing this significant trophy for the Institute. It pays homage to the story of the young Renata Thormann Procianoy, who dedicated two years of her life to helping her mother, Nora Thormann, find a diagnosis and treatment for a rare breast cancer. Thanks to this help, Nora was recruited for clinical research, was treated and recovered.
Unfortunately, Renata died some time later in an accident. Her mother then wanted to leave her daughter's name marked in the fight against cancer, through support for clinical research - the main reason for the existence of the Cura Project Institute, which fights daily to finance scientific studies and research in the treatment and cure of cancer.
To learn more about the Cura Project projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
The second edition of the Cura Meetings meeting will take place on June 10, during the Best of ASCO 2022, in São Paulo.
The new edition of the meeting CURE MEETINGS, organized by Cura Project Institute will deepen the discussions and debate on a topic that was highlighted at our last event, held at the Best of San Antonio Breast Cancer Symposium, which took place at the end of last April, the 29th. The proposal for the next Meetings will be to discuss “The public policy challenges aimed at regulating and encouraging cancer research in Brazil”.
Cura Meetings will take place in a hybrid way, on the day June 10, from 14:00 to 17:30, at the Pullman Ibirapuera Hotel, in São Paulo, on the occasion of the Best of ASCO 2022, an important event that will discuss the recent scientific advances that were presented at ASCO Annual Meeting 2022, the world's leading oncology event, which includes the LACOG and Ethics.
It is already known that research and innovation are fundamental requirements for reducing cancer incidence, but we also know that joint effort in the promotion of structural actions it is a globally recognized need. With the participation of renowned medical researchers, NGO leaders, patient reports and companies involved in encouraging cancer research, the Cura Meetings emerged from the need to expand the knowledge and engagement of different sectors of society to reduce the incidence of cancer in Brazil.
Click here and register for the event for free
Check out the CURA MEETINGS schedule below:
June 10 - 2 pm at 5:30pm
*ASCO News 2022 - Distance between scientific knowledge and what is offered to the population. Speaker: Dr. Carlos Barrios (oncologist);
*The importance of PRONON for funding research. Speaker: Dr. Paulo Hoff (oncologist);
*Legal status of clinical research in Brazil - PL 7082/2017. Speaker: Dr. Fábio Franke (oncologist);
*Presentations of successful cases funded by incentive programs. Speakers: Fábio Fedozzi from ABRALE and the CURA Project Institute
*Debate with NGO leaders, Politicians and Public Officials
*Launch of a mobilization campaign
*Closing
The 2nd edition of the event created by the Cura Project Institute concluded with a social mobilization mission
On June 10th, the Cura Project Institute held another edition of Cura Meetings, an event that aims to bring together medical researchers, representatives of NGOs and civil society, in discussions in favor of clinical oncology research in Brazil.
In an intense afternoon filled with many positive and constructive discussions, Cura Project Institute, with the support of LACOG (Latin American Cooperative Oncology Group), Ethics and Daiichi-Sankyo Brazil, Took up the topic “The challenges of public policies aimed at regulating and encouraging cancer research in Brazil” to an essential framework for the fight against cancer in our country.
O Cura Meetings, which in this edition took place on the occasion of Best Of ASCO 2022 Annual Meeting, in São Paulo, in person and online, put common interests and the importance of joint efforts in social mobilization to reactivate the program PRONON — National Oncology Care Support Program, an important government grant that allows companies taxed for “real profit” to allocate up to 1% of their Income Tax to fund Research and whose regulations expired at the end of 2021. The Cura Project Institute is now fighting to reactivate the program, which benefits clinical research, such as NEOSAMBA, approved by the program last year.
In the latest edition of Meetings, The participation of the National Cooperation Project Coordinator of Ministry of Health, Marcela Iwano. In addition to it, we also highlight the participation of Dr. Paul Hoff, president of the Brazilian Oncology Society (SBOC), who spoke about the importance of PRONON to promote clinical research, since he participated in the creation of the program, which was established by Law No. 12,715/2012.
In the debate on the topic, moderated by Dr. Rafael Laurindo and Dr. Ricardo Caponero, It also included the participation of Dr. Fábio Franke, director of the Clinical Research Alliance, as well as the always essential presence of Dr. Carlos Barrios. The oncologist and founder of LACOG brought to the meeting the news of Annual Congress of the American Society of Clinical Oncology — ASCO 2022. In addition to them, the executive director of ABRALE, Fábio Fedozzi, addressed the success stories financed through incentive programs, and the Senator Mara Gabrilli, who attended the video meeting, in which he emphasized the importance of the permanence of PRONON and the support for Cura Project Institute.
The event was attended in person by representatives of ABRACRO, Oncogia, ABRALE, scientific committee of Cura Project Institute And the research patient Iramara Fluminhan, in addition to several other institutions and patients that participated through the live broadcast on YouTube.
O Cura Project Institute Also thanks to all the participants in the second edition of Cura Meetings, with an important mission ahead with the launch of social mobilization for the reactivation of the program PRONON and in favor of public policies aimed at regulating and encouraging oncological research in Brazil.
To learn more about the Cura Project projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
Created by the Cura Project Institute, the meeting brought together renowned doctors, NGOs and companies to discuss scientific research.
The first edition of the Cure Meetings! Created by the Cura Project Institute, with support from LACOG (Latin American Cooperative Oncology Group), the meeting was part of the program Brazilian Breast Cancer Conference, at the Best of San Antonio Breast Cancer Symposium, and promoted several discussions among renowned doctors in the area on various topics, and provided an opportunity for the public to learn about the benefits and challenges for carrying out research in the fight against cancer.
In this edition, we have 3 different meetings: the Cure Meetings Donors, with the institutions involved in carrying out and developing Neosamba Research; Cura Medical Meetings, who addressed the topic “Innovation in research funding and patient recruitment”; and Cura Meetings NGOs, aimed at leaders of health NGOs and Patient Associations.
O Cura Meetings NGOs It included lectures by renowned doctors and a discussion about “Clinical Research and Social Inclusion”. At the time, we were attended by the following institutions: Abrale, Oncoguia Institute, Red Alianza Latina, Institute Side by Side by Side for Life, Women's Network to Fight Cancer, Oncology Observatory and Overcoming Cancer Institute, TJCC Movement, as well as several others that participated online. In addition, we rely on remote testimonials from research patients Iramara Fluminhan and Ilma Lopes, essential for understanding the practical reality of those who participate in scientific studies. On the occasion, we also highlight the distinguished presence of the doctors Dr. Ricardo Caponero, Dr. Laís Souza, Dr. Eduardo Zucca, Dr. Ruffo Freitas Junior, Dr. Luciana Landeiro and Dr. José Márcio Figueiredo.
The success of the event was only possible due to the participation of everyone who was with us online and in person! We thank everyone and especially LACOG and our speakers!
On June 10, we will have a new edition of Cura Meetings! Soon, we will bring you new information. Wait!
To learn more about the Cura Project projects, visit our Donation tab, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
With the objective of expanding the knowledge and engagement of different sectors of society to reduce the incidence of cancer in Brazil, the Cura Project Institute will hold a series of meetings called “Cura Meetings” in 2022, which will promote meetings and discussion among renowned doctors in the area, on various topics and giving the public the opportunity to learn about the benefits and challenges for carrying out research in the fight against cancer.
The premiere of Cura Meetings will take place on April 29, during the Best of San Antonio Breast Cancer Symposium, organized by GBECAM — LACOG, at the Intercontinental Hotel in São Paulo.
For this event, three meetings are reserved: Care for Meetings Donors, where the institutions involved in carrying out and developing Neosamba Research, sponsored by incentive law, will be presented with its benefits for society and for donor companies. The meeting Cura Meetings NGOs, with an approach to the topic “Clinical Research and Social Inclusion” with the participation of NGO leaders and renowned medical researchers and the third meeting, the Cura Medical Meetings, where it will be discussed about “Innovation in research funding and patient recruitment”, focused on the medical field.
The Cura Project Institute is a non-profit institution, based in Brazil and unique in Latin America, whose objective is to finance academic research in the area of oncology.
According to the World Health Organization, as early as the next decade, two out of every three people will be diagnosed with cancer, which is expected to become a true epidemic. The consolidation of research activity is one of the solutions to meet the needs of the population, particularly those that depend on the public health system, reducing discrepancies and facilitating access to the best treatments.
To learn more about the Cura Project projects, visit the projectocura.org website, follow our Social Networks @projetocura or contact us at eventos@projetocura.org
The Ministry of Health published, on November 18, in the Federal Official Gazette, the approval of the public notice registered in 2019 by the Cura Project Institute, which benefits the NeoSamba Study in the PRONON - National Oncological Care Support Program. Thus, Pronon opens doors for the Cura Project Institute to have more and more hope in its mission to support oncological research.
According to the Federal Government website, “Pronon's purpose is to encourage actions and services developed by non-profit entities, associations and private foundations that work in the field of oncology. The purpose is to expand the offer of services and expand the provision of medical care; to support the formation, training, and improvement of human resources at all levels; and to carry out clinical, epidemiological, and experimental research.”
The National Oncology Care Support Program was established by Law 12,715/12, which allows companies taxed for “real profit” to allocate up to 1% of their Income Tax to finance research such as the NeoSamba Study, which seeks to raise funds to fund the processing of data for a 100% Brazilian study, which studies a new sequencing of the treatment of HER2-negative breast cancer.
The NeoSamba study is a randomized clinical trial, which is in phase 3, studying a new treatment sequence with neoadjuvant chemotherapy (before breast surgery) and will include the treatment of nearly 500 women over three years.
The approval of the NeoSamba Study in Pronon, which is valid for the 2021 fiscal year, does not guarantee the transfer of funds, and the raising of companies to join the program is the responsibility of the Instituto Cura Project and partner groups.
The link provides access to the Public Notice in its certified version: https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/11/2021&jornal=515&pagina=163
ORDINANCE NO. 538, DATED NOVEMBER 16, 2021
DOU - section I published on 11/18/2021
Companies that are interested in supporting the NeoSamba Campaign can contact the Cura Project Institute through its President Fernanda Schwyter 011.9.3080.0811 or via email: campanhas@projetocura.org
Promoted by the Cura Project Institute, Patient Forum “Inside Cancer — EMama edition”, held on October 6, provided a transformative moment for cancer patients, NGO leaders, and other interested parties. The focus of the event was the update on breast cancer and its treatments and the presentation of the latest research with the biggest names in oncology and clinical research in the country.
The Forum, 100% online and free, received an excellent public reception: more than 300 registered! There were more than 3 hours of programming, with 6 conferences, 1 question session, a major research debate and the participation of 13 professionals in the field.
We had the participation of the specialists:
The Forum was sponsored by Roche, the support of the Cristália Laboratory and LACOG, in addition to the support of the following institutions:
The event also marked the official launch of the “Together we can be stronger than cancer” campaign to raise financial resources to enable phase 3 of the NeoSamba Study to be carried out.
Many thanks to everyone involved: speakers, medical coordinators, moderators, and the Cura team!
Click here to learn more about the Campaign “Together we can be stronger than cancer” and participate!
Brazilian researchers are seeking resources for a study that is close to confirming the best preoperative treatment sequence for breast cancer, benefiting women around the world.
The Cura Project Institute launched the crowdfunding campaign “Together we can be stronger than Cancer” that seeks to raise funds to fund one year of data processing for the Neosamba study, a 100% Brazilian study, which studies a new treatment sequence for HER2-negative breast cancer, with neoadjuvant chemotherapy (before breast surgery) and will include the treatment of almost 500 women over three years.
https://www.youtube.com/watch?v=Sji8EVV7q_4&t=9s
The Neosamba survey is moving towards phase 3, when the number of people investigated for a longer period of time is expanded. However, resources are lacking to begin this process, which Dr. José Bines, oncologist and principal investigator of the study, defines as a “confirmatory scientific study”.
“This is a 100% Brazilian survey and 100% conducted in reference institutions that serve SUS patients. There is no relationship with the pharmaceutical industry. All stages of designing and conducting the study are carried out by the researchers themselves, and now with the Cura Project Institute, which has helped us to raise funds for the completion of phase III”, explains Dr. José Bines.
With the proof of the results in phase 3, in addition to the expansion of access to new therapies, an improvement in the quality of life and the increase in the chance of a cure for patients, an extraordinary benefit will be their immediate application, since the medications are now available in the Brazilian public network, without any additional cost increase.
The Neosamba Phase 3 crowdfunding campaign is an initiative of the Cura Project Institute, in partnership with LACOG (Latin American Cooperative Oncology Group), GBECAM (Brazilian Breast Cancer Studies Group). Actress Patrícia Pillar joined the team as an ambassador for the campaign, acting on a voluntary basis as spokesperson for the cause in the promotional materials. Oncology and mastology doctors are also participating as godmothers and godparents in the campaign.
Learn more and make your donation
To learn more details and support the campaign, interested parties can access the Benfeitoria platform by clicking here. Donations can be made by credit card, bank slip or PIX
It is also possible to make a direct donation to the Cura Project Institute through:
If you would like to make a donation in another way, or as a company (PJ), please contact us by e-mail: campanhas@projetocura.org
Make your donation, share, tell your friends and family! Together we can be stronger than cancer!
Changing that story is up to you!
Follow CURA on social media
© 2023 Cura Project Institute. All rights reserved.
